Isodiol International Inc (OTCMKTS:ISOLF) has announced its second quarter financial statement for the 2019 fiscal year. The report for the period ending September 30, 2018 indicates that the hemp-based company generated total revenue of $8.03 million translating to gross profits of $4.32 million. In its report to investors, the company outlines its major achievements during the Q2 while further projecting a prosperous future. Isodiol announced that it has been featured in the American Health Journal – Innovations in Medicine. The announcement which first appeared on the company’s blog revealed that…